Select Page


Covid-19: Novavax vaccine shows 89% efficacy in UK trials – BBC News

Jan 29, 2021 | Uncategorized | 0 comments

Kate Bingham, who used to chair the UK’s Vaccine Taskforce, said the reason the UK had a good supply of vaccines compared with other countries was because of its ability to get clinical trials completed quickly and at a high standard through the NHS’s registry – with some 400,000 volunteers signing up “before the US even started their Phase 3 studies”.